Why Hyperion Therapeutics Inc. Shares Popped

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Hyperion Therapeutics (NASDAQ: HPTX.DL  ) , a biopharmaceutical company focused on treatment hepatology disorders and other orphan diseases, jumped as much as 15% after publishing the midstage results of its glycerol phenylbutyrate (GPB) study for the treatment of hepatic encephalopathy (HE) -- a worsening of brain function due to reduced liver function -- in the March 2014 issue of Hepatology.

So what: According to Hyperion's results, which tested 178 patients with liver cirrhosis, "GPB significantly reduced the proportion of patients who experienced a HE event (21% compared to 36%), as well as the time to first HE event." With a hazard ratio of 0.56, this would imply a 44% clinical risk reduction in first-time HE events for those taking GPB. Hyperion notes that since the trial met its primary endpoint it will be moving onto a pivotal phase 3 trial later this year or in early 2015.

Now what: There's no way to construe this as anything but good news for Hyperion. GPB demonstrated a meaningful reduction in HE events and length of time noted to first HE event for studied patients. Although Hyperion estimates that its drug could target some 140,000 cirrhosis patients in the U.S., investors should also understand that HE drug competition can be fierce, and Hyperion's GPB would be in no way guaranteed of gaining significant market share. Furthermore, with Hyperion now valued at six times the peak sales of its lone FDA-approved urea-cycle disorder drug Ravicti, I'd suggest that its shares could be nearing a high-water point.

Hyperion Therapeutics may be soaring today, but it'll likely have a really hard time keeping up with this top stock in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2853616, ~/Articles/ArticleHandler.aspx, 9/5/2015 2:02:23 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Sean Williams

A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the healthcare sector and in investment planning topics. You'll usually find him writing about Obamacare, marijuana, developing drugs, diagnostics, and medical devices, Social Security, taxes, or any number of other macroeconomic issues.

Today's Market

updated 4 hours ago Sponsored by:
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASD 4,683.92 -49.58 -1.05%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
HPTX.DL $0.00 Down +0.00 +0.00%
Hyperion Therapeut… CAPS Rating: **